Medical School

Class of 1997: Bradford Holland, M.D., is closing out his term as Chairman of TEXPAC, the Texas Medical Association’s political action committee, and in May will begin serving as President of the Texas Association of Otolaryngology. Dr. Holland, his wife, and four children live in Waco.

Class of 2003: Michael Lutter, M.D., Ph.D., has joined Eating Recovery Center Dallas, a provider of comprehensive treatment for eating disorders. Dr. Lutter will serve as a Staff Psychiatrist. Dr. Lutter, Board Certified in Adult Psychiatry by the American Board of Psychiatry and Neurology, completed the Medical Scientist Training Program at UT Southwestern. Dr. Lutter also served his psychiatry residency at UT Southwestern, where he first became interested in the study and treatment of eating disorders.

Class of 2014: Jeomi Maduka, M.D., is one of 16 people named to the inaugural class of Legends of Ivy League Basketball. Dr. Maduka, an internal medicine resident at Parkland Memorial Hospital, is a 2009 graduate of Cornell University. The 2008 Ivy League Player of the Year, she also received honorable mention All-American honors that year, marking the first time a Cornell player had received national recognition. In addition to playing basketball, Dr. Maduka was also a multiple All-American with the school’s track & field team and still holds several records in that sport at Cornell.

Graduate School

Class of 1993: Ofer Reizes, Ph.D., has been selected to hold the Cleveland Clinic’s first endowed chair supporting research into the causes and treatment of uterine cancer. The Laura J. Fogarty Endowed Chair for Uterine Cancer Research, established by a $1 million gift, was established by Laura Fogarty and her husband, Bob Fogarty, a Cleveland lawyer, in the hope to advance treatments for women with recurrent and metastatic uterine cancer. These cancers also tend to recur after treatment, which led Dr. Reizes and his team to look into cancer stem cells – aggressive cancer cells that are difficult to kill and tend to linger after treatment. He discovered that cancer stem cells treated with cisplatin are activated instead of killed. Dr. Reizes and a colleague identified proteins on the surface of these cells that protect them from cisplatin chemotherapy. With the gift from the Fogarty family, Dr. Reizes will be able to study how these receptors can help oncologists predict which patients will respond well to cisplatin. Dr. Reizes, who joined the Cleveland Clinic in 2006, earned his Ph.D. in molecular pharmacology before completing a postdoctoral fellowship at The Children's Hospital Boston and Harvard Medical School.